Replies to post #179 on Kintara Therapeutics Inc (KTRA)

[Jumpinjackas]

Agreed on many points.

I have followed this before they moved to NAS.

The management is great. I completely agree about doing right then to rush it (and re-do the trial again).

I'm just trying to figure out the entry point here. Based on the clinical trial page, they are only recruiting at one location thus far. So, they are far from getting this over the hump. I will probably look to enter here once they are at least half way through enrollment. I don't see anything to prop up the price here.

[Jumpinjackas]

Maxim contradicts your statement. This make sense why the price has been falling off the cliff. Also, this is why they only have one site thus far.:


In a rarity for uber-bull Maxim Group, it downgrades DelMar Pharmaceuticals (DMPI -2.1%) to Hold citing doubts about its ability to raise sufficient capital to advance lead candidate VAL-083, positioned to enter Phase 3 development in treatment-resistant brain cancer. It adds that management was hopeful that warrant exercises would raise an additional $10M in cash, but with exercise prices from $3.00 - 3.50 and the stock languishing at $1.40, this appears to be a remote near-term possibility


So, I see another funding here soon and it won't be pretty if the price stays here, which I see it doing.